New Drug with Nanoparticles Shows Promise in Killing Cancer Metastases

by time news

2023-09-28 09:40:57

Cancer: New Drug Shows Promise in Killing Metastases

Researchers at Washington University Make Breakthrough Discovery with Nanoparticle Therapy

In a significant breakthrough in cancer research, scientists at Washington University’s Center for Multiple Myeloma Nanotherapy have developed a new drug that could potentially stop tumor growth and kill metastases. The medication utilizes nanoparticles that specifically accumulate in the tissue of detected tumors, effectively targeting cancer cells while leaving healthy tissue unharmed.

The nanoparticles are coated with a light-sensitive substance and, when irradiated with light, become activated. This activation triggers chemical reactions that destroy the tumor cells. The activated nanoparticles induce oxidative stress in the cancer cells, leading to cell damage and disruption of metabolic processes. This stress response also alerts the immune system, which recognizes the damaged cancer cells as foreign and begins attacking them.

However, it is worth noting that while the nanoparticles primarily target cancer cells within the tumor, they also attack any cells in the body that resemble the damaged cancer cells. This includes metastases, which occur when cancer cells spread to other parts of the body.

Further research is necessary to validate the effectiveness of this drug, and these investigations are expected to take several years. Currently, three pilot projects utilizing nanoparticles are underway at the Washington University’s Center for Multiple Myeloma Nanotherapy.

Cancer remains a prevailing concern globally, and Germany is no exception. The German Cancer Research Center predicts approximately 510,000 new cases of cancer in 2022, equating to around 1,400 new cases each day. The most common types of cancer in Germany are breast, colon, prostate, and lung cancer.

Despite these alarming statistics, cancer mortality has significantly decreased in Germany in recent years. In 2020, approximately 230,000 people died from cancer, translating to a death rate of 110 per 100,000 inhabitants.

Nanotechnology Holds Great Potential in Cancer Treatment

Nanotechnology is poised to play a crucial role in future cancer treatment. Drugs like the one developed by the researchers at Washington University may be ready for clinical use in the coming years.

Recognizing the potential of nanotechnology, the federal government has also expressed its support. In the future, nano-based “drug ferries” could be developed, allowing nanoparticles programmed to distinguish between healthy and diseased tissue. These particles would specifically target tumor cells and deliver the active ingredients in a targeted manner, potentially eliminating the need for traditional chemotherapy.

As this groundbreaking research continues to progress, scientists and medical professionals remain hopeful that nanotechnology will revolutionize cancer treatment and improve patient outcomes worldwide.

]
#Nanoparticles #kill #tumors

You may also like

Leave a Comment